Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
NCT00175916
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
853
Enrollment
INDUSTRY
Sponsor class
Conditions
Epilepsy
Interventions
DRUG:
Brivaracetam (ucb 34714)
Sponsor
UCB Pharma